The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1499
ISSUE1499
July 18, 2016
Buprenorphine Implants (Probuphine) for Opioid Dependence
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Buprenorphine Implants (Probuphine) for Opioid Dependence
July 18, 2016 (Issue: 1499)
The FDA has approved subdermal implants of the partial
opioid agonist buprenorphine (Probuphine – Titan) for
maintenance treatment of opioid dependence in patients
stabilized on low to moderate doses of transmucosal
buprenorphine. Probuphine...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.